Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs SkinnyRx
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict68/ 100
Grade C · #140SkinnyRx
Sells compounded tirzepatide as a tablet at the same price as the injection, which almost nobody else does — but its headline rate is the twelve-month rung, charged as a single up-front payment, and the company carries an FDA warning letter from February 2026.
Visit SkinnyRxThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 68/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. SkinnyRx still earns its place — people who want tirzepatide by mouth without paying a premium for skipping the needle, and who can pay a year up front — that is the only tier where the price stops being expensive.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results72
92
Real-world results72
97Price honesty48
97
Price honesty48
96Prescriber access72
96
Prescriber access72
88Formulary choice84
88
Formulary choice84
95Cancellation fairness72
95
Cancellation fairness72
93Member support68
93
Member support68
Price, coverage & features
| Metric | CoreAge Rx | SkinnyRx |
|---|---|---|
| Verdict Score | 94/100 | 68/100 |
| Grade | A | C |
| Semaglutide | $149/mo | $349/mo month-to-month, $299/mo on 4 months, $249/mo on 6 months, $199/mo on a 12-mo prepay |
| Tirzepatide | $349/mo | $399/mo month-to-month either route, $349/mo on the 3-4 month tier, $329/mo on 6 months, $299/mo on a 12-mo prepay |
| Coverage | All 50 states | 47 states and Washington DC — excludes Alabama, Louisiana and Mississippi |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
SkinnyRx
What we like
- Compounded tirzepatide tablets cost exactly what the injection costs at all four terms — $399, $349, $329 and $299 — so avoiding the needle carries no premium here
- Every term and its rate is visible on the product pages before any medical intake, so the ladder can be compared without handing over personal details
- Both molecules by both routes — injectable and tablet or sublingual — plus a separate low-dose line with its own page
- Publishes concrete terms rather than vague ones: free shipping, unlimited provider messaging, a 90-day money-back guarantee, and no charge at all if a clinician decides you are not a candidate
- Names the states it does not serve instead of saying 'select states': 47 states and Washington DC, with the three exclusions stated
The caveats
- The advertised 'as low as $199/mo' semaglutide and '$299/mo' tirzepatide are the twelve-month rungs; month-to-month is $349 and $399. The shop-price helper filters the one-month plan out before picking the longest term, so the monthly rate exists in the data and is engineered not to appear in the headline
- Those discounted rungs are not paid monthly: checkout charges rate × months in one payment on the day you order — $2,388 for the semaglutide year, $3,588 for the tirzepatide year — and auto-renews for the full amount each term. Affirm financing only appears on plans longer than one month, which are exactly the ones needing the lump sum
- The microdose SKUs cost the same as the full dose at every shared term and have a HIGHER floor ($229 against $199 on semaglutide, $319 against $299 on tirzepatide) because they stop at eight months — more money for less drug, and no page says so
- FDA issued this company a warning letter in February 2026; the letter is public in FDA's warning-letter database
- No brand product can actually be bought: Ozempic, Wegovy, Mounjaro and Zepbound carry no purchase price, and the Wegovy and Foundayo pills are marked unavailable. The only priced route there is a $49/mo membership 'plus medication cost', and that cost is not published
- Compounded only and not FDA-approved, dispensed by '503A pharmacies' that are never named, with no named medical director for the programme
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
People who want tirzepatide by mouth without paying a premium for skipping the needle, and who can pay a year up front — that is the only tier where the price stops being expensive.
Visit SkinnyRx Read the full SkinnyRx review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for SkinnyRx does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.